专利检索 ap:("Incyte Corporation") AND inv:"Cooper Taylor" 第 1 页

1.

发明授权
Tricyclic urea compounds as JAK2 V617F inhibitors 有权

公开(公告)号：US12084430B2

公开(公告)日：2024-09-10

申请号：US18122323

申请日：2023-03-16

申请人： Incyte Corporation

发明人： Cooper Taylor , Yanran Ai , Chunhong He , Ke Zhang , Eddy W. Yue

IPC分类号： C07D401/14 , A61P35/00 , A61P35/02 , C07D471/14

CPC分类号： C07D401/14

摘要： The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.

2.

发明公开
TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS 审中-公开

公开(公告)号：US20230295124A1

公开(公告)日：2023-09-21

申请号：US18122323

申请日：2023-03-16

申请人： Incyte Corporation

发明人： Cooper Taylor , Yanran Ai , Chunhong He , Ke Zhang , Zhitong Zheng , Eddy W. Yue

IPC分类号： C07D401/14

CPC分类号： C07D401/14

摘要： The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.